| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |